Zobrazeno 1 - 10
of 33
pro vyhledávání: '"J L, Molinuevo"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Neurologia (Barcelona, Spain). 27(8)
There is evidence of insufficient communication abilities by medical specialists as well as of the limited retentive capacities of patients with Alzheimer disease (AD) and their caregivers. The main reasons for this include the personal limitations o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5a04e7a144db311112ad2dd3daf1f021
https://pubmed.ncbi.nlm.nih.gov/21907464
https://pubmed.ncbi.nlm.nih.gov/21907464
Autor:
J L, Molinuevo, B, Hernández
Publikováno v:
Neurologia (Barcelona, Spain). 26(9)
Many factors influence the satisfaction and quality of life of informal caregivers of non-responder patients with Alzheimer disease (AD). Among these include, the course of the disease, cognitive impairment and behavioural disturbances of the patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4fc9525c6f85be9166c764bd2cacba15
https://pubmed.ncbi.nlm.nih.gov/21803459
https://pubmed.ncbi.nlm.nih.gov/21803459
Autor:
J L, Molinuevo
Publikováno v:
Revista de neurologia. 52(2)
The symptomatic treatment of Alzheimer's disease is currently carried out using a twofold therapeutic approach involving acetylcholinesterase inhibitors, whose mechanism of action is based on the selective inhibition of this enzyme, and memantine, wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::71099a10e643e29e56a7301a95736a6f
https://pubmed.ncbi.nlm.nih.gov/21271549
https://pubmed.ncbi.nlm.nih.gov/21271549
Autor:
A, Lladó, R, Sánchez-Valle, M J, Rey, P, Mercadal, C, Almenar, D, López-Villegas, J, Fortea, J L, Molinuevo
Publikováno v:
Neurologia (Barcelona, Spain). 25(1)
To describe a novel mutation in exon 5 of the presenilin 1 gene (E120G)associated with early-onset autosomal dominant Alzheimer's disease (AD).The proband was a man who began with memory loss and progressive cognitive decline at the age of 34. His fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3e98b4a21d0b568c8f30b9229c83f477
https://pubmed.ncbi.nlm.nih.gov/20388456
https://pubmed.ncbi.nlm.nih.gov/20388456
Autor:
A, Lladó, J, Fortea, T, Ojea, B, Bosch, P, Sanz, J, Valls-Solé, J, Clarimon, J L, Molinuevo, R, Sánchez-Valle
Publikováno v:
European journal of neurology. 17(7)
To describe a novel mutation (K239N) in the PSEN1 associated with familial Alzheimer's disease (AD).The proband was a man who developed cognitive decline with marked behavioural abnormalities at age 57. At age 70, he was admitted into a psychiatric f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5a0aabe514128051466f3db1ee013b1b
https://pubmed.ncbi.nlm.nih.gov/20158511
https://pubmed.ncbi.nlm.nih.gov/20158511
Publikováno v:
Revista de neurologia. 49(4)
To establish the discriminatory validity of the mini-mental test (MMSE) and the memory alteration test (M@T) for the diagnosis of amnestic mild cognitive impairment (aMCI) and probable Alzheimer's disease (AD), and also to study the association betwe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c2794d3a016afd77ee2fc32dfb84a3c4
https://pubmed.ncbi.nlm.nih.gov/19621317
https://pubmed.ncbi.nlm.nih.gov/19621317
Publikováno v:
Neurologia (Barcelona, Spain). 23(5)
The communication of the diagnosis of Alzheimer's disease (AD) may represent important emotional distress for the patient and his/her caregiver. This present work aimed to investigate if the disclosure of the diagnosis generates any emotional or psyc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4d06924ce14c0af3a4a2b1ac5e3aa3de
https://pubmed.ncbi.nlm.nih.gov/18528790
https://pubmed.ncbi.nlm.nih.gov/18528790
Publikováno v:
Revista de neurologia. 45(5)
There are some neuropsychological test with a good sensibility for cognitive disorders affecting frontal lobe damage. AIM. To provide normative data for test that assess frontal cognitive function in population over 60 years old.110 neurologically he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9912f879bf9a77b0954038701c445496
https://pubmed.ncbi.nlm.nih.gov/17876736
https://pubmed.ncbi.nlm.nih.gov/17876736
Publikováno v:
Neurologia (Barcelona, Spain). 22(6)
Visual perception disorders are frequent in degenerative diseases with posterior cerebral lobe involvement, such as Alzheimer's disease (AD). The main aim of this study is to create a Perception Digital Test (PDT) based on the treatment of digital ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f0d0c0a46f1efcd90d40dcf146c3c480
https://pubmed.ncbi.nlm.nih.gov/17610161
https://pubmed.ncbi.nlm.nih.gov/17610161